Similar articles

• Cytomegalovirus vaccine in renal transplant candidates: progress report of a randomized, placebo-controlled, double-blind trial.

  Balfour HH Jr, Sachs GW, Welo P, Gehrz RC, Simmons RL, Najarian JS. Balfour HH Jr, et al. Birth Defects Orig Artic Ser. 1984;20(1):289-304. Birth Defects Orig Artic Ser. 1984. PMID: 6329368 Clinical Trial. No abstract available.
• Early diagnosis of cytomegalovirus infection in renal transplantation.

  Feletti C, Musiani M, Bonomini V. Feletti C, et al. Proc Eur Dial Transplant Assoc. 1980;17:473-7. Proc Eur Dial Transplant Assoc. 1980. PMID: 6264422 No abstract available.
• Immunological analysis of cytomegalovirus reactivation in renal transplant patients.

  Sakamaki T, Omori K, Kashiwabara H, Hachisu T, Nakazawa R, Tsuchida H, Yokoyama T. Sakamaki T, et al. Transplant Proc. 1989 Feb;21(1 Pt 2):2075-6. Transplant Proc. 1989. PMID: 2540556 No abstract available.
• Immunology of cytomegalovirus: immunosuppressive effects during infections.

  Ho M. Ho M. Birth Defects Orig Artic Ser. 1984;20(1):131-47. Birth Defects Orig Artic Ser. 1984. PMID: 6203569 Review.
• Cytomegalovirus-leukocyte interactions.

  Hirsch MS. Hirsch MS. Birth Defects Orig Artic Ser. 1984;20(1):161-73. Birth Defects Orig Artic Ser. 1984. PMID: 6329360 Review. No abstract available.